DeLIVERing in vivo CRISPR Screens to Study Hepatic Cell-Cell Interactions

Host

Carlos Minutti, PhD, Immunoregulation Lab


Venue

Seminar room

Champalimaud Open Seminar (COpS)

Effective Neural Dynamical System

Memming Park (Neural Dynamics Lab)

 


Moderation

Klaas van Gisbergen (Tissue Immunity Lab)


Venue

Champalimaud Foundation Auditorium 


Registration

Please register via this link.
 

21 August 2025

Tribute to our colleague and friend, Henrique Nabais

With deep sorrow at the passing of Dr. Henrique Nabais, we pay tribute to our colleague and our friend. His unwavering dedication, leadership and professionalism earned him the highest regard and respect from all who knew him. We extend our heartfelt condolences to his family and friends.

Dr. Henrique Nabais led the Gynaecology Unit of the Champalimaud Clinical Centre since 2013. In these years, he left a profound and lasting mark on his colleagues, on the many patients he cared for, and on their families, whose trust he honoured with compassion and excellence.

16 August 2025

Artificial intelligence can help in the non-invasive diagnosis of prostate cancer

An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging (MRI) scans – that is, without resorting to a biopsy. Their findings were published today, 15th of August, in the journal Radiology: Imaging Cancer.

14 July 2025

Contactless Device Reveals Timing of Sleep Disturbances Due to Breast Cancer Treatment

Sleep disturbances in breast cancer patients undergoing neoadjuvant chemotherapy – designed to shrink the tumours prior to surgery – are one of the common side effects of these treatments, which can not only exacerbate other side effects, but also impact prognosis. One of the possible, non-pharmacological strategies to mitigate these disturbances is thought to be physical exercise.

11 July 2025

Better Patient Screening: New AI-Powered Model Automates Medical Report Analysis

Traditional manual analysis of medical reports is extremely time consuming but crucial for accurate diagnosis and effective patient screening. 

In a recently published scientific study, Luís Elvas - Health Data Engineer in the Breast Cancer Research Programme at the Champalimaud Foundation - and colleagues, have shown that fine-tunning language models can be used for automated analysis of medical reports. This approach can streamline daily clinical workflows, improve categorisation of diseases in patients and offer a tool for new clinical research analysis.

Circadian Programs in Tumor-Associated Neutrophils

Host

Ana Luísa Correia, PhD, Cancer Dormancy & Immunity


Venue

Seminar room

Conference on Gynaecological and Urological Cancers

Date and Time

22 September 2025, 2pm - 7:45pm


Location

Auditorium, Champalimaud Foundation, Lisbon


Topic

This conference will discuss the prevention, treatment and challenges of gynaecological, testicular and prostate cancers with leading experts in the field.

 

Programme

Presented by Fernanda Freitas

2:00pm – 2:10pm – Opening Session and Tribute to Dr. Henrique Nabais

20 June 2025

Artificial intelligence may be a reliable tool for screening for early lung cancer in exhaled breath

Lung cancer is the leading cause of cancer-related deaths. One of the reasons for this is that it is difficult to detect and diagnose at an early stage because the currently available methods are impracticable at the population level. 

Connections in the AHR: a Ticket to Multiple Destinations in Host-Microbe Interactions and Therapy

Host

Rita Fior, PhD, Cancer Development and Innate Immune Evasion Lab


Venue

Seminar room

Subscribe to Cancer
Loading
Please wait...